Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Key Drug Launches To Plan For In 2019

Sep 03 2018

• By John Davis

Rocket — A good launch is important if products are to succeed in the marketplace • Source: Shutterstock

Related Content

Alnylam's Overshadowed Givosiran Comes Into The Phase III Light

Jun 28 2017

Ardelyx Outlines Next Phase III Steps For Tenapanor, Ditches RDX7675

Nov 21 2017

Novartis Back In AMD Game With ‘Potential Blockbuster’ Brolucizumab

Nov 12 2017

Pfizer's Three-Pronged Oncology Strategy Includes Expanding Ibrance, Xtandi, Developing Blockbuster Combos

May 22 2018

J&J's Mixed Phase III Data For Esketamine Highlight Challenges In Resistant Depression

May 07 2018

New Mechanism And Oral Activity Underline Selinexor's Role In Multiple Myeloma

May 01 2018

Attention Turns To Celgene's Other Pipeline Prospects Following Second Positive Luspatercept Read-Out

Jul 10 2018

Celgene Maintains Otezla Confidence, But Is Reconsidering IBD Indications

Jul 27 2018

Nabriva Gains New CEO And Near-Market Antibiotic, Claims Leadership Role

Jul 25 2018

Related Companies

Novartis AG

Johnson & Johnson

Bristol Myers Squibb Company

Bayer AG

Gilead Sciences, Inc.

Nabriva Therapeutics plc.

Ardelyx Inc.

Ironwood Pharmaceuticals, Inc.

Allergan plc

Synergy Pharmaceuticals, Inc.

Alnylam Pharmaceuticals Inc.

Acceleron Pharma, Inc.

Pfizer Inc.

Alexion Pharmaceuticals Inc.

Karyopharm Therapeutics

Foamix Pharmaceuticals Ltd.

Ablynx N.V.

Additional Topics

Approvals Launches Market Intelligence Research & Development BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.